Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
Does Antidepressant Use by Breastfeeding Mothers Lead to Autism?
The aim of the current project is to investigate the consequences of developmental exposure to antidepressants...
Are Implanted Prosthetic Legs for Horses Possible?
An unacceptable number of otherwise healthy horses are euthanized each year from lower limb ailments for...